Literature DB >> 20141462

Nonmedical use of promethazine hydrochloride among heroin injectors in Vietnam: unrecognized risks and unintended consequences.

Michael Clatts1, Le M Giang, Lloyd Goldsamt, Vivian Colón-López.   

Abstract

BACKGROUND: Surveillance studies have noted intravenous injection of promethazine hydrochloride (PHC) among populations that use heroin in south and southeast Asia. However, little is known about onset and initiation of PHC use and its relationship to habitual heroin use.
METHODS: As part of a longitudinal study of heroin initiation, a sample of 179 new heroin users, aged 15-27 years, were interviewed between October 2005 and December 2006 in Hanoi, Vietnam. Cox proportional hazard regression analysis was used to characterize age at promethazine initiation and its association with relevant covariates.
RESULTS: 76% reported lifetime use of PHC. Mean age of PHC initiation was 21.3 years, on average 6 months following onset of heroin injection. In multivariate analysis, lifetime use of diazepam [HR = 1.69 (1.17, 2.44); p-value = .01] and injecting heroin for more than 1.58 years [HR = 1.46 (1.04, 2.06); p-value = .03] were associated with PHC initiation.
CONCLUSION: Intravenous injection of PHC is a relatively common practice among young injection heroin users in Hanoi, Vietnam who use it on a situational basis to substitute for heroin (when heroin is not available or when heroin is too costly) or to augment the effects of an inadequate heroin dosing (delaying onset of heroin withdraw). Existing drug prevention strategies in Vietnam are focused primarily on heroin and most new heroin users initiate PHC use without prior knowledge of its high risk for serious vein damage. Future research is needed on the PHC use among heroin users, including long-term medical consequences of PHC exposure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20141462     DOI: 10.3109/10826080903452520

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  8 in total

1.  Accelerated transition to injection among male heroin initiates in Hanoi, Vietnam: implications for early harm reduction interventions.

Authors:  Michael C Clatts; Lloyd A Goldsamt; Le Minh Giang; Vivian Colón-López
Journal:  J Community Health       Date:  2011-12

2.  Promethazine use among chronic pain patients.

Authors:  Kara L Lynch; Brad J Shapiro; Diana Coffa; Scott P Novak; Alex H Kral
Journal:  Drug Alcohol Depend       Date:  2015-02-26       Impact factor: 4.492

3.  Sexual Initiation and Complex Recent Polydrug Use Patterns Among Male Sex Workers in Vietnam: A Preliminary Epidemiological Trajectory.

Authors:  Gary Yu; Lloyd A Goldsamt; Michael C Clatts; Lê Minh Giang
Journal:  Arch Sex Behav       Date:  2016-01-04

4.  Promethazine misuse among methadone maintenance patients and community-based injection drug users.

Authors:  Brad J Shapiro; Kara L Lynch; Tab Toochinda; Alexandra Lutnick; Helen Y Cheng; Alex H Kral
Journal:  J Addict Med       Date:  2013 Mar-Apr       Impact factor: 3.702

5.  Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam.

Authors:  Long Zhang; David D Celentano; Nguyen Le Minh; Carl A Latkin; Shruti H Mehta; Constantine Frangakis; Tran Viet Ha; Tran Thi Mo; Teerada Sripaipan; Wendy W Davis; Vu Minh Quan; Vivian F Go
Journal:  Eur J Gastroenterol Hepatol       Date:  2015-05       Impact factor: 2.566

6.  Substance use among male sex workers in Vietnam: prevalence, onset, and interactions with sexual risk.

Authors:  Gary Yu; Michael C Clatts; Lloyd A Goldsamt; Le M Giang
Journal:  Int J Drug Policy       Date:  2014-11-08

7.  Nonmedical Use of Antihistaminergic Anxiolytics and Other Prescription Drugs among Persons with Opioid Dependence.

Authors:  Disa Dahlman; Tove Abrahamsson; Alex H Kral; Anders Hakansson
Journal:  J Addict       Date:  2016-12-20

8.  Beyond the 'purple drank': Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports.

Authors:  Stefania Chiappini; Fabrizio Schifano; John Martin Corkery; Amira Guirguis
Journal:  J Psychopharmacol       Date:  2021-01-10       Impact factor: 4.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.